Health Affairs January 24, 2019
Tanisha Carino

In the current issue of Health Affairs, David Wamble and colleagues published a new study – What’s Been The Bang For The Buck? Cost-Effectiveness Of Health Care Spending Across Selected Conditions In The US. In it, they examined disease-level cost-effectiveness ratios, analyzing changes over time in medical intervention spending and the associated changes in health outcomes of patients with seven different diagnoses. Over the period 1996 to 2015, they found that changes in treatment for patients with lung cancer, ischemic heart disease, cerebrovascular disease, and HIV/AIDS resulted in both cost savings (reduced spending per person) and improved health. Results were more mixed for the other diseases examined. Outcomes improved but costs rose for patients with breast cancer and diabetes. Outcomes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Investments, Trends
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Katie Couric Talks Colon Cancer, Health Equity And AI
Ernst & Young: Health equity efforts maturing, but data capabilities remain barrier
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time

Share This Article